Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, afaik, the all time low is .007. AMBS just went below a penny.
The chart says over bought, + MACD and BBs narrowing. The MACD may be trying to go negative however.
http://stockcharts.com/h-sc/ui?s=AMBS&p=D&b=5&g=0&id=p28069966078
Back in April there WAS a tradable interval. The pps stabilized for 6 weeks. Now, the chart said overall that it was going to retest three cents, which it did, but for one reason or another, that was a tradable interval.
You may remember that there was a claim of a quadruple bottom, and subsequent activity, perhaps that is what actually caused the very nice trading interval. I would not bet against it.
I would WAIT for a six week stable pps. Who knows when that will be?
I know that when the pps went LOW, it stayed LOW for at least that period of time.
There is no reason to think that you are going to wake up and miss something.
There was talk of a lawsuit, I wonder if that is going to happen, or if there is grounds, legally speaking. I go by the Big ten rules, and really don't like putting any other sets of rules in my head.
I had to almost yell at my brother, but he sold at 18 cents, which is $27 more or less.
I am still looking for a good place to enter as a trade. It is getting closer.
Looking at the next year, they need a Dollar in order to sell shares and fund the company with the current available shares.
That should be doable, but just barely.
They will need some good news in addition.
It can only come from ESS, imo.
There was a very brief time that AMBS was under a penny in 2012. Soon the pps will be there again.
,0102666 on the close with big volume. down 15%
So, the acquisition of too many non revenue producing assets, even ESS, is sinking AMBS.
Now they are entering true ultra penny land and only have 20 million or so shares to dilutively fund the company.
The market in general is going much lower, and so, they are going to have to come up with some real news to make this work.
$0.01146
A little more than a penny. This stock never left penny land.
The very lowest criteria for uplist was $2. That is no longer in play, if it ever was. 76% drop since the RS.
wow, so that takes them way up there in available shares. 14-15million? ballpark? for a useless test.
The pps is way oversold , the macd is positive, and the pps bounced off the lower bbs. If there are no neg annoncements this is a trading opportunity.
has something been filed?
Vivek is almost a billionaire, GC is almost getting sued. AMBS products will more than likely suffer from lack of investment, but most were already abandoned by another company.
So, I would see Vivek as a smart GC. They have a similar idea, except Vivek was able to get funding up front.
you should have settled Gerald
interesting comment.
So what is the deal? Was today actually the last day to expect an uplist based on the recent application? or not?
Three months gross revenue is generally a rule of thumb for sales prices. There are other rules of thumb. If the asset is only worth $50 million a year in revenue, then you have costs and royalties to pay and I wonder if you are going to make much money.
Of note, JN does not think it is worth $500, he thinks it is worth $50 million.
I only read his work on AMBS which until his last two posts, where he started to agree with me, was all horrible. So I can't disagree with you. OTOH, he probably knows enough to value ESS
On the diagnostic side, GC's been getting hosed. JN now admits that Lympro and MS Presice are worthless. Georgetown has a bunch of geniuses there, and as part of their agreement, they got AMBS to agree to invest $10 million in their product, this year, or drop the option.
So, at best, the diagnostics division spent a lot of money for a test that may be available in four years or so.
On the product side, ESS is a product. However JN nows values that entity at just $50 million. If there is one area in which he is skilled it is valuation, since he is a numbers guy and not a biotech guy. So, I will go with that until I have a better number. In that case, AMBS over paid for ESS.
MANF requires a Billion investment.
Eltoprazine requires a hundred million investment more or less on a less than 50-50 shot.
That is the state of the AMBS products.
I am not sure how these things work, but Alibaba was REJECTED from the Hong Kong Stock exchange and accepted at the NYSE, so there may be something to that. That is only anecdotal evidence, but rather interesting, since the Baba IPO was the largest in history.
If I was a professional, and I knew that the company would uplist, I would buy more and not sell. - all things being equal.
http://scr.zacks.com/files/September-2-2015_AMBS_Zeng.pdf
It is $10 million for the Georgetown test. ( another in a long line of don't test my memory. )
Looking for the next flush of a day to buy. $1.6 should be retested.
Well, first you have the run rate. That is a certain amount, you can look that up.
Next is the Georgetown test. They have to come up with $10 million this year to invest in that.
Then there is the ESS study. I am not sure how much the run rate will increase because of all of these studies, but it will be considerable.
Obviously, they were hoping that the pps would be $10 and not $2, and so they could run through those shares pretty quickly.
I am pretty sure that the run rate's been $2 million a month. You should check that however.
My mistake. Aus $ is 1.4323 US $, so the conversion is more than that. ( even better )
IOW, the ADRs are trading at a discount to the shares.
.115AU$ is $2.3 in US ADS. Time to buy.
I am thinking that you are not referring to Supertech but superconductor technologies, STI, or the stock symbol, SCON.
Supertech does not sell wire, or cell phone tower accessories.
The lower limit for uplist was $4. Then there are conditions assoc with $3 and $2.
$2 is the absolute lower limit.
I do not know if the company meets the other criteris, JN posted on Seeking alpha saying they did not. I do not know one way or the other.
JP usually gets these things right and he said they can uplist.
HOWEVER that is ONLY if the pps holds at $2 and the stock gods shine down upon AMBS.
I follow an solar energy company. They trade on this market and just got $100 million in financing that valued their stock a LOT higher than at current prices. ( that stock is worth the price )
Maybe AMBS can get some of that.
Which three are these? ESS, MSPrecise and ??? Eltoprazine?
So, they had no news. I guess no news is good news.
1.60 is the low. That low will be retested by the end of tomorrow, and in the next two weeks at the very outside.
It is a chance to load up on your favorite stock.
And frankly, if it hits $1 it should finally be a long term buy. That is $.006666. I do not believe the pps got that low in 2012, although, I could be off by a little there.
Trading in general is going to be furious the next couple of days.
http://stockcharts.com/freecharts/gallery.html?$BTK
So much for the biotexh bull.this is the biotech index. Not a stock
That link notes that there is only 750K out of $3 million on the Army grant. Now, the army has a lot of money, and this will have DOD applications so they will probably fund whatever it takes frankly, but that 750K is notable.
The stock is being valued in consideration of the shares that will be needed to dilute the current float. If you triple the current market cap, you are certainly not overvalued.
That is interesting, the buying came in at 1.80. That was at .012 cents.
that is pretty interesting.
Right, the board diluted themselves out of control of the company, and so they will no longer be able to vote for dilution.
The board overreached and so, even if they get THIS dilution, they will only be able to raise a small amount of money with that number of shares.
Assuming that they made the other criteria, which JN doubted, the pps is NOW below the very minimum for the Nas. The very minimum is $2.
The financial workings of late, do not make sense. I follow another company that IS on the Naz. They have no trouble raising money, since they have a product.
The company had 13 mill shares authorized. There was no need to go to 33 right now. They could have waited until the next meeting.
Uplist was more important.
Instead they tried to do both at once and ran into difficulty.
I have not crunched the numbers, only eyeballed them, but 6 million available shares at 7.50 ( really about $5 ) is $30 million in real dollars that they could have raised by selling the rest of the A/S ( 7 - 13 million)
If I do not have this right, I am sure someone will correct me. I am not sure why they needed all of that authorization at this time.
yes sorry
0.14666 cents at the moment.
I never thought I would see JN get off the boat. This is the JN affect.